Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
August 29, 2026
Munich
AI in Pulmonary Hypertension Demonstrates Progress—with Caveats
Multi-Omics Brings New Clarity to the REHAB-PH Trial
Translating Evidence Into Practice: Myosin Inhibition Across the HCM Spectrum
August 30, 2026
How Symptoms Shape Caregiver Burden in ATTR-CM
Ryan Quigley
PiB PET Uncovers Hidden ATTR-CM
Moving the Needle in oHCM: The Era of Cardiac Myosin Inhibitors
Early Recognition of ATTR-CM: Key Signs and Diagnostic Strategies
Valmiki Maharaj, MD
Recognizing and Managing Swelling in ATTR-CM
Steve Jackson, PharmD
Kevin S. Shah, MD
Understanding Real-World Testing Patterns in ATTR-CM
Ronald Witteles, MD
Translating Evidence Into Action: Nonsteroidal MRAs in Patients With HF
Muthiah Vaduganathan, MD, MPH
Koichiro Kinugawa, MD
Michael Böhm, MD
Understanding the Mechanisms Behind Resistant Hypertension
Jan Basile, MD
Michael J. Bloch, MD, FAHA, FASH, FNLA, FSVM, FACP
Finerenone Subgroup Analyses in Patients With Glomerulonephritis
Brendon Neuen, MBBS, PhD
Swing for the Fences – LDL-C as the Power Hitter
J.A. Randy Englert, MD, FACC
Matthew Malachowski, Pharm. D., MHA
Crossing Home Plate – Building a Winning Team Culture
ASCVD Playbook | Closing the Gaps, One Inning at a Time
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.